News Articles Tagged: Direct-Acting Antivirals

Analyzing Telaprevir's Market Withdrawal: Lessons in Pharmaceutical Economics and Strategy

Explore the economic factors and strategic decisions that led to Telaprevir's market withdrawal, contrasting it with newer treatments. Insights from NINGBO INNO PHARMCHEM CO.,LTD. on the competitive landscape.

The Evolution of Hepatitis C Treatment: From Telaprevir to Modern DAAs

Trace the progress of Hepatitis C treatment, starting with the advent of Telaprevir and moving towards today's highly effective Direct-Acting Antivirals (DAAs). Insights from NINGBO INNO PHARMCHEM CO.,LTD.